Press Release June 30, 2021Merck Animal Health Survey Reveals Pet Owners Need Advice Navigating Their Pets' Transition to Normalcy 0 0 Share
Company Ticker News June 30, 2021Merck's Keytruda-Chemo Combo Wins European Approval In Esophagus Cancer 0 0 Share
Company Ticker News June 30, 2021Merck, Johnson & Johnson and Bristol-Myers Seen as Most Active in M&A 0 0 Share
Press Release June 29, 2021European Commission Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy for Certain Patients With Esophageal Cancer or HER2-Negative Gastroesophageal Junction (GEJ) Adenocarcinoma 0 0 Share
Company Ticker News June 27, 2021Week 26 MDA Breakout Stocks - July 2021: Short-Term Picks To Give You An Edge 0 0 Share
Company Ticker News June 26, 2021Forget Dogecoin: These Dogs of the Dow Are More Likely to Make You Rich 0 0 Share
Company Ticker News June 26, 2021Merck Desperate To Get Back In Coronavirus Race, With A Pill 0 0 Share
Press Release June 24, 2021LYNPARZA® (olaparib) Approved in China for the Treatment of Certain Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer 0 0 Share
Company Ticker News June 24, 2021Merck (MRK) Dips More Than Broader Markets: What You Should Know 0 0 Share
